Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration

Table 3

Whole group anatomical and visual measurements following aflibercept.

	Baseline mean (IQR)	Final mean (IQR)	value
Central retinal thickness (m)	370.57 (280.5–428.5)	295.7 (232–335.5)	<0.001
Visual acuity (logMAR)	0.56 (0.29–0.99)	0.53 (0.24–0.71)	0.301
Total retinal fluid (mm^3)	4.81 (3.06–7.6)	4.37 (2.82–7.18)	<0.001

logMAR, logarithm of minimum angle of resolution.
IQR, interquartile range.